Drug
Sofpironium clinical trials
Also written BBI-4000.
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Botanix Pharmaceuticals (8)
Related medicines
As reviewed, each with the page that says it.
- One of Cholinergic Antagonists source
Studies
Open first, then newest update. How each study uses Sofpironium is read from its arms, and is right about nine times in ten.
Testing it · 8
- Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)CompletedPhase 3Botanix PharmaceuticalsNCT03836287Written as Sofpironium Bromide Gel, 15%
- Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)CompletedPhase 3Botanix PharmaceuticalsNCT03948646Written as Sofpironium Bromide, 15%
- A Safety Study of BBI-4000 Gel in Patients With Axillary HyperhidrosisCompletedPhase 3Botanix PharmaceuticalsNCT03627468Written as Sofpironium Bromide Gel, 5%
- A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar HyperhidrosisCompletedPhase 2Botanix PharmaceuticalsNCT02682238Written as BBI-4000, 15%
- A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary HyperhidrosisCompletedPhase 2Botanix PharmaceuticalsNCT03024255Written as BBI-4000 gel, 5%
- A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary HyperhidrosisCompletedPhase 2Botanix PharmaceuticalsNCT02336503Written as BBI-4000 Gel, 5%
- A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary HyperhidrosisCompletedPhase 2Botanix PharmaceuticalsNCT03785587Written as Sofpironium Bromide Gel, 15%
- A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary HyperhidrosisCompletedPhase 1Botanix PharmaceuticalsNCT02058264Written as BBI-4000
Codes
What other systems call Sofpironium · ClinicalTrials.gg INT002130
- MeSH (NLM) C000731748SofpironiumOne source NLM
- UNII (FDA) 00Y6A5AJU6SOFPIRONIUMConfirmed FDA, NLM, Wikidata
- Wikidata Q27231384sofpironiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C220858SofpironiumOne source FDA
- DrugBank DB19325One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000731748 | Sofpironium | One source NLM |
| UNII (FDA) | 00Y6A5AJU6 | SOFPIRONIUM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27231384 | sofpironium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C220858 | Sofpironium | One source FDA |
| DrugBank | DB19325 | — | One source Wikidata |
Also registered as sofpironium bromide (UNII 7B2Y1932XU).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.